We are investigating a new treatment option for individuals diagnosed with kidney cancer. The goal is to see if this treatment can improve outcomes compared to standard care.
Health conditions and diseases that the clinical trial is designed to study and treat.
Metastatic Renal Cell Carcinoma (RCC) is a type of kidney cancer that has spread to other parts of the body, often accompanied by End-Stage Renal Disease (ESRD), where the kidneys can no longer function properly. This condition can lead to serious health issues and requires careful management.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.